Biotechnology, mainly including fermentation technology and modern biotechnology, uses living organisms (or their substances) such as microorganisms, flora, and fauna, combined with advanced scientific and technological means, to improve products, plants, and animals according to predetermined designs, or cultivate microorganisms for special purposes.
In recent years, modern biotechnology represented by genetic engineering, cell engineering, enzyme engineering, and fermentation engineering has developed rapidly and is increasingly influencing and changing people\'s production and lifestyle. From the perspective of downstream applications, biotechnology is widely used in various fields such as biopharmaceuticals, bio-services, bio-agriculture, bio-industry, and bioinformatics.
The biopharmaceutical field is the largest downstream application market for biotechnology. Biopharmaceuticals is the process of applying bioengineering technology to the field of drug manufacturing, with genetic engineering methods being the most important. By utilizing cloning and tissue culture techniques, DNA is cut, inserted, connected, and recombined to obtain biopharmaceutical products. Research has shown that over 60% of biotechnology achievements are concentrated in the pharmaceutical industry. It is used to develop characteristic new drugs or improve traditional medicine, which has led to significant changes in the pharmaceutical industry and the rapid development of biopharmaceuticals. According to our research data, the total revenue of the global biotechnology industry market is expected to reach $560087 million in 2023, among which the biotechnology market revenue applied to the biopharmaceutical field is estimated to be $3484.88 million, and the market share is expected to be as high as 62.22%.
Global Biotechnology Market Revenue and Market Share by Application in 2023
Source: www.globalmarketmonitor.com
From the perspective of the competitive landscape, the concentration of the global biotechnology industry market is relatively low. Data shows that the total share of biotechnology market revenue for the top 3 enterprises in the industry was 11.18% in 2020, while the total share of the top 6 enterprises was 18.28%. The top three companies were Amgen, Danaher, and Celgene, with market revenue shares of 4.07%, 3.85%, and 3.26% in 2020, respectively.
Market Revenue and Share of Major Enterprises in 2020
|
Enterprises
|
Market Revenue (M USD)
|
Market Share
|
|
Amgen
|
22800
|
4.07%
|
|
Danaher
|
21591
|
3.85%
|
|
Celgene
|
18236
|
3.26%
|
|
Top3
|
62727
|
11.18%
|
|
Top6
|
102408
|
18.28%
|
Source: www.globalmarketmonitor.com
Nowadays, the application of biotechnology in the medical
field has penetrated various aspects such as gene therapy, gene editing, and
personalized medicine. In the future, with the continuous development of
biotechnology, we can expect the emergence of more accurate and effective
disease diagnosis and treatment plans. In addition, in the field of
agriculture, biotechnology can help us develop crops with a higher yield, and
produce safer and more effective agricultural products. Meanwhile, through gene
editing technology, we can also breed and protect rare animals. Overall, the
application prospects of biotechnology are broad, and it is expected that the
market will experience greater growth in the coming years.
For more information, please click: 《China Biotechnology Industry Market Research Report 2023-2029》。
Chinese